BBHW Supports DEA Scheduling of 7-OH and Three Related Drugs is an Important Step to Take Dangerous, Synthetic Products Off of the Market
The Drug Enforcement Administration (DEA) announced today that 7-hydroxymitragynine (7-OH) and three related synthetic drugs, pseudoindoxyl, MGM15 and MGM16, are being officially placed on Schedule I of the Controlled Substances Act. This scheduling decision aligns regulation with science, a move Botanicals for Better Health and Wellness (BBHW) strongly supports.
